Ardigen
Krakow, PL · Founded 2015 · 136 employees on LinkedIn · 1 known investors
Find your way into Ardigen
Sign up to find every way you can get introduced to Ardigen
- Your email: who you already know at Ardigen, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ardigen team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.
Founders & leadership
Board
P
PrzewiezlikowskiFounder, CEO (of Ryvu Therapeutics), President of Supervisory Board
Investors · 1
Funding
SEC filings, press & company announcements$5.4M disclosed across 1 round · 2020
- $5.4MraisedSep 2020 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ardigen do?
- Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.
- Who are Ardigen's investors?
- Ardigen's investors include Pointer.Capital.
- How much funding has Ardigen raised?
- Ardigen has disclosed $5.4M raised across 1 round.
- Where is Ardigen headquartered?
- Ardigen is headquartered in Krakow, PL.


